Piper Sandler Expands Healthcare Equity Research with the Hiring of Dave Westenberg

Rhea-AI Summary

Piper Sandler Companies (NYSE: PIPR) has announced the appointment of Dave Westenberg as managing director and senior research analyst, focusing on the life science tools & diagnostics sector. Westenberg joins from Guggenheim Partners, bringing over eight years of experience in equity research. His educational background includes a B.S. from San Francisco State University and a Master’s in Finance from Università Bocconi. The addition strengthens Piper Sandler's growing Healthcare platform, aimed at capitalizing on the rapid growth and innovation within this sector.

Positive

• Addition of experienced analyst, enhancing research capabilities in a growing sector.
• Focus on the rapidly growing life science tools & diagnostics sector, increasing strategic importance.

Negative

• None.

MINNEAPOLIS--(BUSINESS WIRE)-- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of managing director and senior research analyst, Dave Westenberg. He will cover the life science tools & diagnostics sector.

Prior to joining Piper Sandler, Westenberg was a senior equity research analyst at Guggenheim Partners where he covered the tools and omics and animal health sectors. He brings 8+ years of sector coverage and worked in the life sciences industry earlier in his career. Westenberg received a B.S. in Business Administration from San Francisco State University and a Masters, Finance from Università Bocconi in Italy.

“We remain impressed by the caliber of individuals choosing to join the Piper Sandler equity research team and we are excited to welcome Dave to our growing Healthcare platform. The Life Science Tools & Diagnostics sector is experiencing rapid growth and technological innovation, which is increasing the sector’s strategic importance to the global Healthcare landscape,” said Michael Cox, co-head of global equities at Piper Sandler.

ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

View source version on businesswire.com: https://www.businesswire.com/news/home/20211222005103/en/

Pamela Steensland

Tel: 612 303-8185

pamela.steensland@psc.com

Source: Piper Sandler Companies

FAQ

Who is the new managing director at Piper Sandler and what is his role?

Dave Westenberg is the new managing director and senior research analyst at Piper Sandler, focusing on the life science tools & diagnostics sector.

What experience does Dave Westenberg bring to Piper Sandler?

Dave Westenberg brings over eight years of experience in equity research, previously working at Guggenheim Partners covering tools and omics.

How does the addition of Westenberg affect Piper Sandler's Healthcare platform?

His addition is expected to strengthen Piper Sandler's Healthcare platform, allowing the firm to better capitalize on growth in the life sciences sector.

What educational background does Dave Westenberg have?

Westenberg holds a B.S. in Business Administration from San Francisco State University and a Master's in Finance from Università Bocconi in Italy.

What is the stock symbol for Piper Sandler?

The stock symbol for Piper Sandler is PIPR.